Compounds > tyrosine

tyrosine and Blood Clot

tyrosine has been researched along with Blood Clot in 108 studies

Research

Studies (108)

TimeframeStudies, this research(%)All Research%
pre-19905 (4.63)18.7374
1990's12 (11.11)18.2507
2000's50 (46.30)29.6817
2010's37 (34.26)24.3611
2020's4 (3.70)2.80

Authors

AuthorsStudies
Gaidukova, KA; Gurova, NA; Khaliullin, FA; Kucheryavenko, AF; Pavlov, VN; Samorodov, AV; Sirotenko, VS; Spasov, AA1
Esposito, G; Ettori, F; Ferlini, M; Lettieri, C; Marchese, A; Musumeci, G; Passamonti, E; Pierini, S; Rigattieri, S; Romano, M; Tarantini, G; Testa, L; Tiberti, G1
Heemskerk, JWM1
Chu, E; Diallo, F; Emani, S; Emani, SM; Pereira, LM; Piekarski, BL; Thiagarajan, R; Wesley, MC1
Çavuşoğlu, Y; Iskenderov, K; Mutlu, F; Şenol, U; Tahmazov, S; Ulus, T1
Choudhary, MI; Moin, SF; Waheed, H1
Chourdakis, E; Hahalis, G; Koniari, I; Kounis, NG; Patsouras, N; Roumeliotis, A; Soufras, G; Tsigkas, G1
Brennan, SO; Chitlur, M1
López, JA1
Karnicki, K; McBane, RD; Wysokinski, WE1
Gao, YX; Li, L; Li, Y; Sun, TW; Yu, XZ; Yuan, YQ; Zhao, XY1
Çakıcı, M; Cetin, M; Polat, M; Suner, A1
Austin, D; Christie, J; de Belder, MA; Hennigan, B; Mackay, DF; Morley, R; Oldroyd, KG; Pell, JP1
Natarajan, D1
Heemskerk, JW; Lancé, MD; Lionikiene, AS; Mastenbroek, TG; Mutch, NJ; Swieringa, F; van der Meijden, PE; Whyte, CS1
Baek, JY; Chae, YH; Chang, TS; Jang, JY; Min, JH; Wang, SB; Yu, DY1
Harmon, C; King, S; Short, M1
Ahn, JH; Chang, IB; Jun, HS; Kim, JH; Oh, JK; Song, JH1
Dreysse, S; Falk, V; Kaufmann, F; Krabatsch, T; Kretzschmar, A; Müller, M; Pergantis, P; Pieri, M; Potapov, EV; Scandroglio, AM1
Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD1
Cao, Z; Gao, L; Zhang, H1
Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q1
Dembo, L; Lovett, M; O'Driscoll, G; Thomas, MD; Wood, C1
Abrams, CS; Bezman, NA; Brass, LF; Jordan, MS; Kahn, ML; Koretzky, GA; Lian, L1
Burke, A; Chernysh, I; Fitzgerald, GA; Heijnen, HF; Ischiropoulos, H; Koliakos, G; Liebler, DC; Nagaswami, C; Parastatidis, I; Stamer, S; Thomson, L; Visser, J; Weisel, JW1
Beiras-Fernandez, A; Jiru, P; Kowert, A; Reichart, B; Schmoeckel, M; Spannagl, M; Weis, M1
Adamo, MF; Alagha, A; Chubb, AJ; Moman, E; Nolan, KB1
Chiariello, M; D'andrea, C; Esposito, G; Piscione, F1
Beresford-Cleary, NJ; Chelliah, R; Connolly, TM; Cortas, K; Daga, S; Feuerstein, GZ; Fox, KA; Lucking, AJ; Newby, DE; Tattersall, L1
Mocatta, TJ; Paton, LN; Richards, AM; Winterbourn, CC1
Bates, ER; Chetcuti, S; Grossman, PM; Gurm, HS; Meier, P; Tamhane, U1
Atherton, RE; Gibbins, JM; Jones, CI; Kaiser, WJ; Moraes, LA; Sage, T; Spyridon, M1
Dai, K; Li, S; Liu, G; Shi, Q; Wang, Y; Wang, Z; Zhang, W1
Boissinot, M; Cleyrat, C; Girodon, F; Harousseau, JL; Hermouet, S; Issa, JP; Jelinek, J; Ponge, T1
Lin, X; Liu, Y; Ni, Z; Wan, X; Yang, X; Zhang, L; Zhang, Z1
Anselmi, M; Bolognese, L; Bressers, M; Bristot, L; Campo, G; Colangelo, S; De Cesare, N; Gambetti, S; Garcia-Garcia, HM; Garg, S; Monti, M; Moreno, R; Parrinello, G; Rodriguez, AE; Sarno, G; Serruys, PW; Valgimigli, M1
Chen, K; Febbraio, M; Li, W; Major, J; Rahaman, SO; Silverstein, RL1
Dziegielewski, P; Fu Zhu, L; Harris, J; Seikaly, H; Singh, P1
Cheng, CF; Cheng, WT; Kikuchi, T; Lian, WS; Lin, H1
Celikel, R; Jing, H; McClintock, RA; Mendolicchio, GL; Moore, KL; Roberts, JR; Ruggeri, ZM; Varughese, KI; Zarpellon, A1
Schneider, DJ1
Badenhorst, PN; Lamprecht, S; Meiring, SM; Roodt, JP; van Rensburg, WJ1
De Caterina, R; Grove, EL; Huber, K; Kristensen, SD; Moliterno, DJ; Neumann, FJ; Würtz, M1
Cho, JY; Endale, M; Kamruzzaman, SM; Kim, SD; Lee, WM; Park, HJ; Park, JY; Park, MH; Park, TY; Rhee, MH1
Aksakal, E; Inci, S; Karakelleoğlu, S; Sevimli, S1
Davutoglu, V; Ercan, S; Ozer, O; Sari, I; Yuce, M1
Bellandi, F; Cutlip, D; De Luca, G; Dudek, D; Emre, A; Gabriel, HM; Gibson, CM; Gyongyosi, M; Huber, K; Maioli, M; Noc, M; Rakowski, T; Secco, GG; van 't Hof, AW; Zeymer, U; Zorman, S1
Bender, M; Bösl, M; Braun, A; Gupta, S; Hermanns, HM; Morowski, M; Nagy, Z; Nieswandt, B; Premsler, T; Sickmann, A1
Boylan, B; Cooley, BC; Gao, C; Hayes, V; McKenzie, SE; Newman, DK; Newman, PJ; Poncz, M; Rauova, L; Zhi, H1
Ambrosini, V; Battaglia, S; Cioppa, A; Lo Muzio, L; Rubino, P; Salemme, L; Sorropago, G; Tesoria, T1
Adewuya, O; Bian, K; Irie, Y; Murad, F; Onigu-Otite, E1
Azarbal, B; Cercek, B; Finkelstein, A; Kaul, S; Rukshin, V; Shah, PK; Tsang, V1
CHAMBERS, DA; SALZMAN, EW1
Harrington, RA; Nguyen, CM1
Dai, W; Kloner, RA1
Dubois, C; Reigner, SC; Riederer, MA; Steiner, B1
Goto, S; Ishida, H; Tamura, N1
Allie, AA; Allie, DE; Allie, SD; Chaisson, GA; Fail, PS; Hebert, CJ; Keller, VA; Khan, MA; Khan, MH; Lirtzman, MD; Mitran, EV; Stagg, SJ; Vitrella, DA; Walker, CM; Wyatt, CH1
Gibbins, JM; Hubbard, GP; Lovegrove, JA; Wolffram, S1
del Conde, I; Kleiman, NS; López, JA; Nabi, F; Thiagarajan, P; Tonda, R1
Eberli, FR; Hess, OM; Locher, S; Meier, B; Remondino, A; Rey, C; Seiler, C; Togni, M; Tüller, D; Wenaweser, P; Windecker, S1
Cohen, EA; Fort, S; Godin-Edgecombe, M; Madan, M; Naqvi, SZ; Paradiso-Hardy, FL; Phillips, AM; Radhakrishnan, S; Reis, M; Shanmugasegaram, S; Sparling, C1
Concannon, MJ; Farias, CL; Kazmier, FR; Puckett, CL; Yates, YJ1
Biscione, C; Crea, F; De Vita, M; Maria Leone, A; Mongiardo, R; Niccoli, G; Rebuzzi, A1
Cardaioli, P; Giordan, M; Magro, B; Maronati, L; Rigatelli, G; Roncon, L; Zonzin, P1
Goto, S; Ishida, H; Ruggeri, ZM; Tamura, N1
Ahrens, I; Bassler, N; Bode, C; Chen, YC; Fitzgerald, D; Hagemeyer, CE; Kenny, D; Meade, G; Moran, N; Peter, K; Schwarz, M; Stoll, P; Ylanne, J1
Burns, G; Meola, S; Mohammad, S; Solen, K; Sukavaneshvar, S1
Fontana, P1
Bacchetti, T; Mazzanti, L; Moroni, C; Nanetti, L; Provinciali, L; Raffaelli, F; Silvestrini, M; Taffi, R; Vignini, A1
De Maeyer, B; De Maeyer, M; Deckmyn, H; Fontayne, A; Matsushita, T; Yamashita, M1
Chung, TL; Holton, LH; Pumplin, DW; Rodriguez, ED; Silverman, RP; Taylor, JA1
Bittmann, I; Brandl, U; Brenner, P; Burdorf, L; Erhardt, M; Hammer, C; Jöckle, H; Michel, S; Mordstein, V; Reichart, B; Rössle, M; Schmoeckel, M; Thein, E1
Kim, DJ; Lee, KO; Lee, KY; Seo, KD1
Allegretto, N; Barbera, F; Bird, JE; Giancarli, MR; Ogletree, ML; Schumacher, WA; Seiffert, D; Wong, P1
Głowiński, S; Worowski, K1
Asai, F; Nakashima, M; Takiguchi, Y; Wada, K1
Baumgartner, HR; Kirchhofer, D; Steiner, B; Tschopp, TB1
Cook, JJ; Holahan, MA; Lynch, JJ; Lynch, RJ; Mellott, MJ; Ramjit, DR; Sitko, GR; Stabilito, II; Stranieri, MT; Zhang, G1
André, P; Arbeille, B; Bal dit Sollier, C; Caen, JP; Drouet, LO; Drouet, V; Hainaud, P1
Anderson, KM; Coller, BS; Weisman, HF1
Bidmon, HJ; Buchkremer-Ratzmann, I; Mayer, B; Witte, OW; Wu, J; Zilles, K1
Brosstad, F; Goggin, T; Lehne, G; Midtvedt, K; Nordal, KP1
Kleiman, NS1
Edmunds, LH; Gorman, JH; Hiramatsu, Y; Rao, AK; Sun, L1
Dunn, A1
Atar, S; Birnbaum, Y; Luo, H; Nagai, T; Siegel, RJ1
Aronoff, GR; Blankenship, KA; Dawson, CB; Dean, WL1
Ali, A; Grady, KJ; Patil, S; Schreiber, TL1
Mohammad, SF; Solen, KA; Sukavaneshvar, S1
Collinson, J; Flather, M; Gomma, A; Purcell, H1
Cap, A; Cohen, R; Eberhardt, RT; Farber, HW; Forgione, MA; Goldschmidt-Clermont, PJ; Heydrick, S; Klings, ES; Leopold, JA; Loscalzo, J; Moldovan, NI; Rudd, MA; Stark, R; Trolliet, M; Yaghoubi, M1
Eto, K; Goto, S; Handa, S; Ichikawa, N; Isshiki, T; Kim, JY; Nagaoka, Y; Sakakibara, M; Shimazaki, T; Yoshida, M1
Goto, S; Handa, M; Ikeda, Y; Murata, M1
Arnold, N; Bullens, SL; Bunting, S; Chamberlain, J; Chico, TJ; Crossman, DC; Francis, SE; Gadek, TR; Gunn, J; Horton, M; Knolle, J; Lipari, MT; Peyman, A; Quan, C; Shepherd, L; Stilz, HU1
Bassand, JP1
Vernon, SM1
Böck, K; Calais, P; Herrlinger, JD; Schommer, B; Schröder, J1
Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK1
Aulich, A; Junghans, U; Seitz, RJ; Siebler, M; Wittsack, HJ1
Galli, M1
Cercek, B; Finkelstein, A; Kaul, S; Rukshin, V; Shah, PK; Tsang, V1
Hirata, K; Isobe, M; Katsuramaki, T; Kimura, H; Kimura, Y; Matsuno, T; Meguro, M; Nagayama, M; Nui, A1
Henry, RG; Little, JW; McIntosh, BA; Miller, CS1
Budzynski, AZ; Marder, VJ1
Murray, M; Smith, GF1
Kopper, PH; Nelson, DL1

Reviews

14 review(s) available for tyrosine and Blood Clot

ArticleYear
Snake Venom: From Deadly Toxins to Life-saving Therapeutics.
    Current medicinal chemistry, 2017, Volume: 24, Issue:17

    Topics: Animals; Anticoagulants; Batroxobin; Blood Coagulation; Captopril; Peptides; Snake Venoms; Snakes; Thrombosis; Tirofiban; Toxins, Biological; Tyrosine

2017
Glycoprotein IIb/IIIa inhibitors: The resurgence of tirofiban.
    Vascular pharmacology, 2016, Volume: 78

    Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Thrombosis; Tirofiban; Tyrosine

2016
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
    Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:3

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2009
Current issues with glycoprotein IIb-IIIa antagonists.
    Current drug targets, 2011, Volume: 12, Issue:12

    Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Anticoagulants; Eptifibatide; Hemostasis; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2011
Contemporary use of glycoprotein IIb/IIIa inhibitors.
    Thrombosis and haemostasis, 2012, Volume: 107, Issue:2

    Topics: Abciximab; Acute Coronary Syndrome; Angioplasty; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Thrombosis; Tirofiban; Tyrosine

2012
Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Volume: 3, Issue:6

    Topics: Abciximab; Angioplasty; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Restenosis; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombosis; Tirofiban; Tyrosine

2003
[Update on antithrombotic treatments in arterial diseases].
    Revue medicale suisse, 2007, Feb-07, Volume: 3, Issue:97

    Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2007
The anti-GPIIb-IIIa agents: fundamental and clinical aspects.
    Haemostasis, 1996, Volume: 26 Suppl 4

    Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Mice; Multicenter Studies as Topic; Oligopeptides; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombosis; Tirofiban; Tyrosine

1996
Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists.
    Coronary artery disease, 1998, Volume: 9, Issue:9

    Topics: Abciximab; Acetates; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

1998
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
    Haemostasis, 2000, Volume: 30 Suppl 3

    Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor

2000
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
    Haemostasis, 2000, Volume: 30 Suppl 2

    Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2000
Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
    Cardiology clinics, 2001, Volume: 19, Issue:2

    Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Artery Bypass; Dalteparin; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Nadroparin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Transaminases; Tyrosine

2001
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
    Perfusion, 2001, Volume: 16, Issue:5

    Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine

2001
Antithrombotic agents: implications in dentistry.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2002, Volume: 93, Issue:5

    Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin

2002

Trials

5 trial(s) available for tyrosine and Blood Clot

ArticleYear
[Prevention of non-acute stent thrombosis after drug-eluting stent implantation].
    Zhonghua wei zhong bing ji jiu yi xue, 2013, Volume: 25, Issue:5

    Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Warfarin

2013
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    American heart journal, 2016, Volume: 177

    Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine

2016
Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI).
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Jul-31, Volume: 22

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Combined Modality Therapy; Coronary Angiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Thrombectomy; Thrombosis; Tirofiban; Tyrosine

2016
Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:12

    Topics: Blood Platelets; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Collagen; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Female; Flavonols; Glucosides; Humans; Immunoblotting; Male; Phosphorylation; Platelet Activation; Platelet Aggregation; Quercetin; Signal Transduction; Thrombosis; Time Factors; Tyrosine

2004
Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial).
    The American journal of cardiology, 2005, Jun-01, Volume: 95, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Drug Therapy, Combination; Elective Surgical Procedures; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Integrin alpha2; Integrin beta3; Male; Membrane Glycoproteins; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2005

Other Studies

89 other study(ies) available for tyrosine and Blood Clot

ArticleYear
Antithrombotic Activity of the Antiplatelet Agent Angipur on the Model of Arterial Thrombosis in Rats with Isoproterenol-Induced Myocardial Infarction.
    Bulletin of experimental biology and medicine, 2022, Volume: 172, Issue:3

    Topics: Animals; Fibrinolytic Agents; Isoproterenol; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis; Tyrosine

2022
Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry.
    Journal of interventional cardiology, 2022, Volume: 2022

    Topics: Aged; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Reperfusion; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2022
More than reverting tyrosine kinases.
    Blood, 2022, 09-01, Volume: 140, Issue:9

    Topics: Humans; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Thrombosis; Tyrosine

2022
Platelet Inhibition With IV Glycoprotein IIb/IIIa Inhibitor to Prevent Thrombosis in Pediatric Patients Undergoing Aortopulmonary Shunting.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2020, Volume: 21, Issue:6

    Topics: Child; Humans; Pharmaceutical Preparations; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombosis; Treatment Outcome; Tyrosine

2020
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2017, Volume: 45, Issue:2

    Topics: Acute Coronary Syndrome; Aged; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Thrombosis; Tirofiban; Tyrosine

2017
Perioperative Management of Dual Antiplatelet Therapy.
    Journal of cardiothoracic and vascular anesthesia, 2018, Volume: 32, Issue:3

    Topics: Aspirin; Elective Surgical Procedures; Hemorrhage; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine

2018
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted).
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:6

    Topics: Afibrinogenemia; Aspartic Acid; Binding Sites; Chromatography, High Pressure Liquid; Dimerization; Fibrinogen; Gene Deletion; Genetic Variation; Histidine; Humans; Infant; Male; Mutation; Phenotype; Sequence Analysis, DNA; Thrombosis; Tyrosine

2013
The platelet Fc receptor: a new role for an old actor.
    Blood, 2013, Mar-07, Volume: 121, Issue:10

    Topics: Animals; Blood Platelets; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Receptors, Immunologic; Signal Transduction; Thrombosis; Tyrosine

2013
Platelet recruitment to venous stent thrombi.
    Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:4

    Topics: Acetates; Animals; Blood Platelets; Female; Iliac Vein; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Swine; Thrombosis; Tyrosine

2013
Giant left atrial appandage thrombus due to atrial fibrillation: successful treatment with warfarin.
    Platelets, 2014, Volume: 25, Issue:4

    Topics: Atrial Appendage; Atrial Fibrillation; Female; Humans; Platelet Aggregation Inhibitors; Thrombosis; Tyrosine

2014
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, Volume: 10, Issue:10

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Survival Analysis; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2015
Acute thrombosis during left main stenting using tap technique in a patient presenting with non-ST-segment elevation acute coronary syndrome.
    Cardiovascular revascularization medicine : including molecular interventions, 2015, Volume: 16, Issue:4

    Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Drug Combinations; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2015
Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
    Blood, 2015, Apr-16, Volume: 125, Issue:16

    Topics: Blood Platelets; Crotalid Venoms; Fibrin; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Flow Cytometry; Hemostatics; Hirudins; Lectins, C-Type; Microscopy, Confocal; Oligopeptides; Phosphatidylserines; Protein Binding; Rheology; Shear Strength; Thrombin; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine; Urokinase-Type Plasminogen Activator

2015
Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function.
    The Journal of biological chemistry, 2015, May-01, Volume: 290, Issue:18

    Topics: Animals; Antioxidants; Blood Platelets; Carotid Artery Diseases; Collagen; Hydrogen Peroxide; Membrane Microdomains; Mice; Peroxiredoxins; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Reactive Oxygen Species; Signal Transduction; Thrombosis; Tyrosine

2015
Thrombus remnant despite intra-arterial thrombolysis for thrombus formation during endovascular treatment of ruptured cerebral aneurysms: Does it harm?
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2016, Volume: 22, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Cerebral Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Male; Middle Aged; Stents; Thrombolytic Therapy; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2016
Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.
    Journal of the American College of Cardiology, 2016, 06-14, Volume: 67, Issue:23

    Topics: Algorithms; Equipment Design; Equipment Failure; Female; Fibrinolytic Agents; Heart-Assist Devices; Humans; Male; Middle Aged; Retrospective Studies; Thrombectomy; Thrombosis; Tirofiban; Tyrosine

2016
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
    BioMed research international, 2016, Volume: 2016

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2016
Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2008, Volume: 27, Issue:8

    Topics: Adult; Anticoagulants; Aspirin; Female; Heart-Assist Devices; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Warfarin

2008
Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo.
    The Journal of experimental medicine, 2008, Aug-04, Volume: 205, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Blood Platelets; CD36 Antigens; Female; Genetic Complementation Test; Integrins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mutagenesis, Site-Directed; Phospholipase C gamma; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein-Tyrosine Kinases; Signal Transduction; Thrombosis; Tyrosine

2008
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.
    The Journal of biological chemistry, 2008, Dec-05, Volume: 283, Issue:49

    Topics: Adolescent; Adult; Fibrin; Fibrinogen; Humans; Microscopy, Immunoelectron; Middle Aged; Nitrogen; Oxidative Stress; Protein Processing, Post-Translational; Protein Structure, Tertiary; Risk Factors; Thrombosis; Tyrosine

2008
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
    The Annals of thoracic surgery, 2009, Volume: 87, Issue:2

    Topics: Acute Coronary Syndrome; Acute Disease; Angina, Unstable; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Postoperative Complications; Preoperative Care; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2009
Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity.
    Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15

    Topics: Arginine; Aspirin; Carboxylic Acids; Catalytic Domain; Chemistry, Pharmaceutical; Drug Design; Esters; Humans; Platelet Activation; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Serine; Thrombosis; Tyrosine

2009
Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:11

    Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug Administration Schedule; Embolism; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Saphenous Vein; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2009
P-selectin antagonism reduces thrombus formation in humans.
    Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:11

    Topics: Adolescent; Adult; Blood; Cells, Cultured; Cross-Over Studies; Double-Blind Method; Humans; Hydroxyquinolines; P-Selectin; Perfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Young Adult

2009
Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction.
    Free radical biology & medicine, 2010, Jan-15, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Humans; Male; Mass Spectrometry; Middle Aged; Myocardial Infarction; Protein Carbonylation; Protein Multimerization; Thrombin; Thrombosis; Tyrosine

2010
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Anilides; Animals; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; PPAR gamma; Prostaglandin D2; Protein-Tyrosine Kinases; Rosiglitazone; Signal Transduction; Spectrometry, Fluorescence; Syk Kinase; Thiazolidinediones; Thrombosis; Time Factors; Tyrosine

2010
Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
    Journal of applied physiology (Bethesda, Md. : 1985), 2010, Volume: 108, Issue:5

    Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcium; Chelating Agents; Contractile Proteins; Egtazic Acid; Filamins; Hemostasis; Humans; Hypergravity; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Ristocetin; Thrombosis; Time Factors; Tirofiban; Tyrosine; Weightlessness Simulation

2010
JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5.
    Leukemia, 2010, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Animals; B-Lymphocytes; Base Sequence; Blotting, Western; Case-Control Studies; Cell Line; Colony-Forming Units Assay; Female; Genotype; Humans; Janus Kinase 2; Mice; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Sequence Data; Mutation; Myeloproliferative Disorders; Phenotype; Phosphorylation; Polycythemia; Polymerase Chain Reaction; Proto-Oncogene Proteins c-akt; STAT5 Transcription Factor; Thrombosis; Tyrosine; Young Adult

2010
Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2011, Volume: 17, Issue:5

    Topics: Electrocardiography; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine

2011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolim
    JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Angiography; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine

2011
Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state.
    Blood, 2011, May-26, Volume: 117, Issue:21

    Topics: Animals; Blood Platelets; Blotting, Western; Carotid Artery Thrombosis; Dietary Fats; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Hyperlipidemias; Immunoprecipitation; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-vav; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; src-Family Kinases; Thrombosis; Tyrosine

2011
Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model.
    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2011, Volume: 40 Suppl 1

    Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Drug Therapy, Combination; Fascia; Fibrinolytic Agents; Follow-Up Studies; Free Tissue Flaps; Head and Neck Neoplasms; Heparin; Microsurgery; Neoplasms, Experimental; Plastic Surgery Procedures; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Rats; Rats, Sprague-Dawley; Skin Transplantation; Therapeutic Irrigation; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine; Wound Healing

2011
Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.
    Journal of biomedical science, 2011, Apr-15, Volume: 18

    Topics: Animals; Disease Models, Animal; Endothelial Cells; Fibrosis; Granulocyte Colony-Stimulating Factor; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocarditis; Simvastatin; Thrombosis; Tirofiban; Tyrosine

2011
Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, May-24, Volume: 108, Issue:21

    Topics: Binding Sites; Hemostasis; Humans; Immobilized Proteins; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Protein Structure, Tertiary; Prothrombin; Thrombin; Thrombosis; Tyrosine

2011
Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates.
    Clinical and experimental medicine, 2012, Volume: 12, Issue:4

    Topics: Abciximab; Animals; Antibodies, Monoclonal; Anticoagulants; Disease Models, Animal; Immunoglobulin Fab Fragments; Primates; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2012
Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.
    British journal of pharmacology, 2012, Volume: 167, Issue:1

    Topics: Adenosine Triphosphate; Animals; Blood Coagulation; Calcium; Cell Adhesion Molecules; Collagen; Cyclic AMP; Cyclic GMP; Ginsenosides; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Mitogen-Activated Protein Kinases; P-Selectin; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane A2; Tyrosine

2012
Acute myocardial infarction during the early postpartum period successfully treated with tirofiban.
    European review for medical and pharmacological sciences, 2012, Volume: 16 Suppl 1

    Topics: Acute Disease; Adult; Coronary Angiography; Electrocardiography; Heart Valve Prosthesis; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Platelet Aggregation Inhibitors; Postpartum Period; Thrombosis; Tirofiban; Tyrosine

2012
Huge left atrial appendage thrombus in a patient with atrial fibrillation: successful treatment with tirofiban.
    Platelets, 2013, Volume: 24, Issue:4

    Topics: Aged; Atrial Appendage; Atrial Fibrillation; Female; Humans; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2013
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors.
    The Journal of invasive cardiology, 2012, Volume: 24, Issue:7

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Electrocardiography; Eptifibatide; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Regional Blood Flow; Regression Analysis; Retrospective Studies; Risk Factors; Survival Rate; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2012
CLP36 is a negative regulator of glycoprotein VI signaling in platelets.
    Circulation research, 2012, Nov-09, Volume: 111, Issue:11

    Topics: Animals; Blood Coagulation Tests; Blood Platelets; Blotting, Western; Calcium; Collagen; Female; Gene Expression; Immunoreceptor Tyrosine-Based Activation Motif; Inositol 1,4,5-Trisphosphate; LIM Domain Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Microscopy, Electron, Transmission; Phosphorylation; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thrombosis; Transcription Factors; Tyrosine

2012
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
    Blood, 2013, Mar-07, Volume: 121, Issue:10

    Topics: Animals; Arterioles; Blood Platelets; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Platelet Aggregation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, IgG; Receptors, Immunologic; Signal Transduction; Thrombosis; Tyrosine; Veins

2013
Percutaneous femoral artery angioplasty with stent-in-stent technique and tirofiban administration.
    The Journal of invasive cardiology, 2002, Volume: 14, Issue:10

    Topics: Angioplasty, Balloon; Female; Femoral Artery; Fibrinolytic Agents; Humans; Middle Aged; Recurrence; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2002
Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide.
    Nitric oxide : biology and chemistry, 2003, Volume: 8, Issue:1

    Topics: Aneurysm; Animals; Blotting, Western; Cell Wall; Coronary Vessels; Disease Models, Animal; Hemorrhage; Immunohistochemistry; Inflammation; Lacticaseibacillus casei; Macrophages; Male; Mice; Mucocutaneous Lymph Node Syndrome; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Thrombosis; Time Factors; Tyrosine; Vasculitis

2003
Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
    Journal of cardiovascular pharmacology, 2003, Volume: 41, Issue:4

    Topics: Animals; Arteriovenous Shunt, Surgical; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2003
INHIBITION OF ADP-INDUCED PLATELET AGGREGATION BY SUBSTITUTED AMINO-ACIDS.
    Nature, 1964, Nov-14, Volume: 204

    Topics: Adenine Nucleotides; Adenosine Diphosphate; Alanine; Alkylation; Amino Acids; Aminocaproates; Aminocaproic Acid; Arginine; Blood Platelets; Butyrates; Glutamine; Glycine; Guanidines; Leucine; Pharmacology; Phenylalanine; Platelet Aggregation; Proline; Research; Thrombosis; Tyrosine

1964
Glycoprotein IIb/IIIa inhibitors and no-reflow.
    Journal of the American College of Cardiology, 2004, Jan-21, Volume: 43, Issue:2

    Topics: Animals; Coronary Circulation; Fibrinolytic Agents; Humans; Microcirculation; Models, Animal; Myocardial Infarction; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thrombosis; Tirofiban; Tyrosine; Vascular Patency

2004
Thrombin binding to GPIbalpha induces integrin alphaIIbbeta3 dependent platelet adhesion to fibrin in ex vivo flowing whole blood.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:2

    Topics: Acetates; Anticoagulants; Blood; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Membrane Glycoproteins; Membrane Proteins; Oligopeptides; Peptide Fragments; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Thrombin; Thrombosis; Tyrosine

2004
Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
    Journal of the American College of Cardiology, 2004, Jul-21, Volume: 44, Issue:2

    Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Arginine; Blood Platelets; Collagen; Eptifibatide; Fibrinolytic Agents; Hemorheology; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Peptides; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombosis; Tirofiban; Tyrosine

2004
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2004, Volume: 11, Issue:4

    Topics: Aged; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intravenous; Ischemia; Leg; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Tenecteplase; Thrombolytic Therapy; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine

2004
Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:5

    Topics: Apoptosis; Blood Platelets; Cell Membrane; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Vitro Techniques; Membrane Glycoproteins; Monocytes; P-Selectin; Phosphatidylserines; Phosphorylation; Platelet Activation; Solubility; Thrombin; Thrombosis; Tyrosine

2005
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.
    European heart journal, 2005, Volume: 26, Issue:12

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Vessel Prosthesis; Death, Sudden, Cardiac; Emergency Treatment; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Survival Analysis; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2005
The effect of tirofiban on microvascular thrombosis: crush model.
    Plastic and reconstructive surgery, 2005, Volume: 116, Issue:1

    Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Femoral Artery; Isotonic Solutions; Microsurgery; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Random Allocation; Rats; Rats, Sprague-Dawley; Ringer's Lactate; Thrombosis; Tirofiban; Tyrosine; Vascular Patency

2005
Delayed stenting of a thrombotic saphenous vein graft after intravenous tirofiban pretreatment.
    International journal of cardiology, 2006, Jun-07, Volume: 110, Issue:1

    Topics: Aged; Coronary Disease; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Stents; Thrombosis; Tirofiban; Tyrosine

2006
Iliac artery thrombosis after aortic balloon counterpulsation: treatment with intraarterial tirofiban, manual thrombectomy and stenting.
    International journal of cardiology, 2006, Oct-10, Volume: 112, Issue:3

    Topics: Aged; Coronary Angiography; Fibrinolytic Agents; Heparin; Humans; Iliac Artery; Infusions, Intra-Arterial; Intra-Aortic Balloon Pumping; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombectomy; Thrombosis; Tirofiban; Tyrosine

2006
Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Journal of the American College of Cardiology, 2006, Jan-03, Volume: 47, Issue:1

    Topics: Adenosine Monophosphate; Blood Platelets; Calcium Channel Blockers; Calcium Signaling; Collagen; Humans; In Vitro Techniques; Lanthanum; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thrombosis; Tirofiban; Tyrosine

2006
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Circulation research, 2006, Jul-07, Volume: 99, Issue:1

    Topics: Amino Acid Motifs; Animals; Antibodies; Bleeding Time; Blood Platelets; Carotid Artery Diseases; Chlorides; Complementarity Determining Regions; Eptifibatide; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Conformation; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2006
Mitigation of device-associated thrombosis and thromboembolism using combinations of heparin and tirofiban.
    The journal of extra-corporeal technology, 2006, Volume: 38, Issue:3

    Topics: Animals; Anticoagulants; Drug Therapy, Combination; Heparin; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Sheep; Stents; Thromboembolism; Thrombosis; Tirofiban; Tyrosine

2006
Reactive oxygen species plasmatic levels in ischemic stroke.
    Molecular and cellular biochemistry, 2007, Volume: 303, Issue:1-2

    Topics: Aged; Atherosclerosis; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Reactive Oxygen Species; Thrombosis; Tyrosine

2007
Paratope and epitope mapping of the antithrombotic antibody 6B4 in complex with platelet glycoprotein Ibalpha.
    The Journal of biological chemistry, 2007, Aug-10, Volume: 282, Issue:32

    Topics: Amino Acid Sequence; Amino Acids; Antibodies; Antibodies, Monoclonal; Binding Sites, Antibody; Chemistry, Pharmaceutical; Drug Design; Epitope Mapping; Epitopes; Membrane Glycoproteins; Membrane Proteins; Molecular Conformation; Molecular Sequence Data; Mutagenesis, Site-Directed; Platelet Glycoprotein GPIb-IX Complex; Software; Thrombosis; Tyrosine

2007
Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.
    Plastic and reconstructive surgery, 2007, Volume: 120, Issue:5

    Topics: Anastomosis, Surgical; Animals; Anticoagulants; Aspirin; Drug Therapy, Combination; Heparin; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Random Allocation; Rats; Rats, Sprague-Dawley; Thrombosis; Tirofiban; Tyrosine; Vascular Patency

2007
Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Transplantation, 2007, Dec-27, Volume: 84, Issue:12

    Topics: Adult; Animals; Animals, Genetically Modified; Antibodies; CD55 Antigens; Complement C3; Complement C4; Creatine Kinase; Disaccharides; Fibrin; Fibrinolytic Agents; Heart; Heart Transplantation; Humans; Male; Myocardium; Swine; Thrombosis; Tirofiban; Transplantation, Heterologous; Tyrosine

2007
Rescue use of tirofiban for acute carotid in-stent thrombosis.
    Yonsei medical journal, 2008, Feb-29, Volume: 49, Issue:1

    Topics: Acute-Phase Reaction; Angiography; Carotid Artery Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stents; Thrombosis; Tirofiban; Tyrosine

2008
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
    Thrombosis research, 2008, Volume: 123, Issue:1

    Topics: Animals; Anticoagulants; Arginine; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Chlorides; Ferric Compounds; Guinea Pigs; Hemostasis; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombosis; Tirofiban; Tyrosine

2008
Cathepsin D activity and protein degradation products content in the walls of varicose veins of the lower limbs.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1981, Volume: 13, Issue:3

    Topics: Adult; Cathepsins; Female; Humans; Male; Middle Aged; Proteins; Saphenous Vein; Thrombosis; Tyrosine; Varicose Veins

1981
Comparison of antithrombotic effects of GPIIb-IIIa receptor antagonist and TXA2 receptor antagonist in the guinea-pig thrombosis model: possible role of TXA2 in reocclusion after thrombolysis.
    Thrombosis and haemostasis, 1995, Volume: 73, Issue:4

    Topics: Acetates; Animals; Biphenyl Compounds; Femoral Artery; Guinea Pigs; Heptanoic Acids; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Thromboxane; Thrombosis; Thromboxane A2; Tyrosine

1995
Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.
    Blood, 1995, Nov-15, Volume: 86, Issue:10

    Topics: Acetates; Anticoagulants; Blood Coagulation; Blood Platelets; Collagen; Enzyme Activation; Factor Xa; Fibrin; Fibrinopeptide A; Hemorheology; Humans; In Vitro Techniques; Macromolecular Substances; Perfusion; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1995
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:1

    Topics: Adenosine Diphosphate; Animals; Coronary Circulation; Dogs; Female; Hemostasis; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Streptokinase; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine

1995
Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:1

    Topics: Acetates; Animals; Anticoagulants; Capillary Action; Collagen; Fibrin; Guinea Pigs; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1996
Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions.
    Neuroscience, 1998, Volume: 82, Issue:2

    Topics: Animals; Cerebral Infarction; Immunohistochemistry; Ischemic Attack, Transient; Isoenzymes; Lectins; Male; NADPH Dehydrogenase; Nitric Oxide Synthase; Rats; Rats, Wistar; Somatosensory Cortex; Thrombosis; Tyrosine

1998
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction.
    Thrombosis and haemostasis, 1998, Volume: 79, Issue:6

    Topics: Acetates; Adenosine Diphosphate; Adult; Aged; Bleeding Time; Creatinine; Female; Half-Life; Hematoma; Humans; Kidney Diseases; Kidney Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tyrosine

1998
Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
    Thrombosis and haemostasis, 1999, Volume: 82, Issue:1

    Topics: Animals; Cardiopulmonary Bypass; Fibrinolytic Agents; Intraoperative Complications; Papio; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thrombosis; Tirofiban; Tyrosine

1999
Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors.
    Connecticut medicine, 1999, Volume: 63, Issue:8

    Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

1999
Lamifiban.
    Drugs in R&D, 1999, Volume: 1, Issue:5

    Topics: Acetates; Animals; Dogs; Guinea Pigs; Haplorhini; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thrombosis; Tyrosine

1999
Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
    Thrombosis research, 1999, Dec-15, Volume: 96, Issue:6

    Topics: Albumins; Blood Coagulation; Contrast Media; Fibrin; Fibrinolytic Agents; Fluorocarbons; Heparin; Humans; In Vitro Techniques; Sodium Chloride; Solubility; Sonication; Stents; Thrombosis; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tyrosine

1999
Tyrosine phosphorylation of human platelet plasma membrane Ca(2+)-ATPase in hypertension.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 1

    Topics: Adult; Blood Platelets; Calcium-Transporting ATPases; Case-Control Studies; Cell Membrane; Female; Humans; Hypertension; In Vitro Techniques; Male; Middle Aged; Phosphorylation; Risk Factors; Thrombosis; Tyrosine

2000
Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2000, Volume: 49, Issue:2

    Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Fatal Outcome; Female; Hemoptysis; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Alveoli; Thrombosis; Tirofiban; Tyrosine

2000
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:2

    Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relationship, Drug; Edetic Acid; Embolism; Equipment and Supplies; Equipment Design; Evaluation Studies as Topic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Scattering, Radiation; Stents; Thrombosis; Tirofiban; Tyrosine

2000
The role of tirofiban in acute coronary syndromes.
    International journal of clinical practice, 2000, Volume: 54, Issue:2

    Topics: Angina, Unstable; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Tyrosine

2000
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.
    The Journal of clinical investigation, 2000, Volume: 106, Issue:4

    Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Cystathionine beta-Synthase; Dinoprost; Disease Models, Animal; Endothelium, Vascular; F2-Isoprostanes; Heterozygote; Humans; Hyperhomocysteinemia; In Vitro Techniques; Lipid Peroxides; Mice; Mice, Mutant Strains; Nitroprusside; Reactive Oxygen Species; Risk Factors; Thrombosis; Tyrosine; Vasodilation

2000
[Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
    Journal of cardiology, 2000, Volume: 36, Issue:2

    Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Collagen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Microscopy, Fluorescence; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2000
Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty.
    Circulation, 2001, Feb-27, Volume: 103, Issue:8

    Topics: Acetates; Angioplasty, Balloon, Coronary; Animals; Cell Adhesion; Disease Models, Animal; Immunohistochemistry; Muscle, Smooth, Vascular; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Vitronectin; Swine; Thrombosis; Tunica Intima; Tyrosine

2001
[Lysis of an extensive thrombus in the internal carotid artery using a glycoprotein IIb/IIIa receptor antagonist].
    Deutsche medizinische Wochenschrift (1946), 2001, Jun-08, Volume: 126, Issue:23

    Topics: Aphasia, Broca; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Paralysis; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking; Thrombosis; Tirofiban; Tomography, X-Ray Computed; Tyrosine

2001
Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
    Radiology, 2001, Volume: 221, Issue:3

    Topics: Aged; Basilar Artery; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine

2001
Platelet inhibition after glycoprotein IIb/IIIa inhibitor therapy.
    Circulation, 2001, Dec-18, Volume: 104, Issue:25

    Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine

2001
Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
    Circulation, 2002, Apr-23, Volume: 105, Issue:16

    Topics: Animals; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation; Blood Pressure; Dogs; Eptifibatide; Fibrinolytic Agents; Heart Rate; Heparin; Magnesium Sulfate; P-Selectin; Peptides; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Time Factors; Tirofiban; Tyrosine

2002
A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver.
    Transplantation, 2002, May-15, Volume: 73, Issue:9

    Topics: Amidines; Animals; Aspartate Aminotransferases; Enzyme Inhibitors; Female; Heterocyclic Compounds, 2-Ring; Hot Temperature; Ischemia; L-Lactate Dehydrogenase; Liver; Liver Circulation; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Reperfusion Injury; Survival Analysis; Swine; Thrombosis; Tissue Distribution; Tyrosine

2002
Determination of human fibrinopeptide A by radioimmunoassay in purified systems and in the blood.
    Thrombosis et diathesis haemorrhagica, 1975, Dec-15, Volume: 34, Issue:3

    Topics: Amino Acid Sequence; Batroxobin; Fibrinogen; Fibrinopeptide A; Humans; Immune Sera; Protein Binding; Radioimmunoassay; Retinal Diseases; Retinal Vessels; Thrombophlebitis; Thrombosis; Tyrosine

1975
Thrombosis and blood coagulation. A study by quantitative N-terminal amino acid analysis.
    Archives of pathology, 1970, Volume: 89, Issue:3

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Autoanalysis; Binding Sites; Blood Coagulation; Cattle; Chemical Phenomena; Chemistry; Edetic Acid; Fibrin; Fibrinogen; Glycine; Humans; Immunoelectrophoresis; Models, Biological; Thrombin; Thrombosis; Tyrosine

1970
A new method for lysis of blood clots in vivo.
    Transactions of the Kansas Academy of Science. Kansas Academy of Science, 1966,Spring, Volume: 69, Issue:1

    Topics: Animals; Dogs; Fibrinolytic Agents; Gluconates; Thrombosis; Tyrosine

1966